NOTCH1 and B-cell chronic lymphocytic leukemia: In contrast, NOTCH1 mutations in CLL (also associated with trisomy 12) are associated with low surface expression of CD20, a feature that may confer poor response to rituximab-based immuno-chemotherapy.6